Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 1 16Phase NA 10Phase 3 10Phase 1/2 6Phase 2/3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 4Ovarian Neoplasms 4Pancreatic Neoplasms 3Sarcoma 2Hematopoietic and Lymphoid System Neoplasm 2Glioma 2Glioblastoma 2Brain Neoplasms 2Urogenital Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Fallopian Tube Neoplasms 1Endometrial Serous Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Oncolytic Virotherapy 4Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3Tobacco Use Cessation Devices 2Positron-Emission Tomography 2perflutren 1pembrolizumab 1osimertinib 1icotinib 1gallium 68 PSMA-11 1dapagliflozin 1dacomitinib 1clevudine 1aldesleukin 1Vitamin A 1Tomography, Emission-Computed, Single-Photon 1Tetrahydrouridine 1Technetium 1Sulfur Hexafluoride 1Sufentanil 1Standard of Care 1Specimen Handling 1Ropivacaine 1Radiotherapy 1Radiosurgery 1Probiotics 1Practice Guidelines as Topic 1Positron Emission Tomography Computed Tomography 1Pentetic Acid 1Nicotine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lung Neoplasms × Specimen Handling × Clear all
NCT07235280 2026-02-19

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

Jonsson Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡